• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D在黑色素瘤治疗中是否已“日薄西山”?

Has Vitamin D Had Its "Time In The Sun" For Melanoma?

作者信息

Huerter Christopher J, Vaudreuil Adam, Agrawal Devendra K, Nguyen Austin Huy

机构信息

Division of Dermatology and Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, Nebraska.

出版信息

J Clin Aesthet Dermatol. 2016 Dec;9(12):11-12. Epub 2016 Dec 1.

PMID:28210393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5300721/
Abstract

Growing evidence suggests a pivotal role for vitamin D in cancers, particularly melanoma. The broad immunologic effects of vitamin D and its signaling axis make for a complex interplay between tumor cells and the immune system. Preclinical evidence suggests vitamin D to have protective effects in melanoma oncogenesis and progression, creating a potential role for vitamin D supplementation in cancer prevention and/or adjuvant therapy. In this commentary, the authors highlight studies of vitamin D in melanoma with clinical implications and call for large clinical trials to definitively determine the role of supplementation in patients to prevent and help treat melanoma.

摘要

越来越多的证据表明维生素D在癌症,尤其是黑色素瘤中起关键作用。维生素D及其信号轴广泛的免疫效应导致肿瘤细胞与免疫系统之间产生复杂的相互作用。临床前证据表明维生素D在黑色素瘤的发生和进展中具有保护作用,这为补充维生素D在癌症预防和/或辅助治疗中创造了潜在作用。在这篇评论中,作者强调了维生素D在黑色素瘤方面具有临床意义的研究,并呼吁开展大型临床试验以明确确定补充维生素D在预防和帮助治疗黑色素瘤患者中的作用。

相似文献

1
Has Vitamin D Had Its "Time In The Sun" For Melanoma?维生素D在黑色素瘤治疗中是否已“日薄西山”?
J Clin Aesthet Dermatol. 2016 Dec;9(12):11-12. Epub 2016 Dec 1.
2
[Potential of Using Vitamin D as an Adjuvant Treatment of Malignant Melanoma].[使用维生素D作为恶性黑色素瘤辅助治疗的潜力]
Klin Onkol. 2017 Fall;30(5):327-336. doi: 10.14735/amko2017327.
3
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors.维生素 D 与黑色素瘤:争议与联合免疫检查点抑制剂的潜在作用
Cancer Treat Rev. 2018 Sep;69:21-28. doi: 10.1016/j.ctrv.2018.05.016. Epub 2018 May 31.
4
Vitamin D and melanoma: state of the art and possible therapeutic uses.维生素D与黑色素瘤:最新进展及可能的治疗用途。
G Ital Dermatol Venereol. 2019 Feb;154(1):64-71. doi: 10.23736/S0392-0488.17.05801-1. Epub 2017 Dec 15.
5
Vitamin D and systemic cancer: is this relevant to malignant melanoma?维生素D与全身性癌症:这与恶性黑色素瘤有关吗?
Br J Dermatol. 2002 Aug;147(2):197-213. doi: 10.1046/j.1365-2133.2002.04960.x.
6
The consequences for human health of stratospheric ozone depletion in association with other environmental factors.平流层臭氧消耗与其他环境因素相关联对人类健康产生的后果。
Photochem Photobiol Sci. 2015 Jan;14(1):53-87. doi: 10.1039/c4pp90033b.
7
The human health effects of ozone depletion and interactions with climate change.臭氧消耗对人类健康的影响及其与气候变化的相互作用。
Photochem Photobiol Sci. 2011 Feb;10(2):199-225. doi: 10.1039/c0pp90044c. Epub 2011 Jan 20.
8
Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.皮肤恶性黑色素瘤结局中维生素D补充剂(ViDMe):一项随机对照试验。
BMC Cancer. 2017 Aug 23;17(1):562. doi: 10.1186/s12885-017-3538-4.
9
Vitamin D and skin cancer.维生素D与皮肤癌
Photochem Photobiol. 2015 Jan-Feb;91(1):201-9. doi: 10.1111/php.12382. Epub 2014 Dec 8.
10
The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer?阳光正负效应带来的挑战:多少太阳紫外线照射量才适合在维生素D缺乏风险和皮肤癌风险之间取得平衡?
Prog Biophys Mol Biol. 2006 Sep;92(1):9-16. doi: 10.1016/j.pbiomolbio.2006.02.010. Epub 2006 Feb 28.

引用本文的文献

1
MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors.富含MicroRNA-21的外泌体作为黑色素瘤发生和进展中的表观遗传调节因子:西方生活方式因素的影响
Cancers (Basel). 2020 Jul 29;12(8):2111. doi: 10.3390/cancers12082111.

本文引用的文献

1
Vitamin D and skin cancer.维生素D与皮肤癌
Photochem Photobiol. 2015 Jan-Feb;91(1):201-9. doi: 10.1111/php.12382. Epub 2014 Dec 8.
2
Decreased VDR expression in cutaneous melanomas as marker of tumor progression: new data and analyses.皮肤黑素瘤中 VDR 表达降低可作为肿瘤进展的标志物:新数据和分析。
Anticancer Res. 2014 Jun;34(6):2735-43.
3
Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.维生素 D 激活酶 1α-羟化酶 (CYP27B1) 的表达在黑色素瘤进展过程中降低。
Hum Pathol. 2013 Mar;44(3):374-87. doi: 10.1016/j.humpath.2012.03.031. Epub 2012 Sep 17.
4
Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review.维生素D受体(VDR)基因多态性与皮肤癌:一项系统评价。
Dermatoendocrinol. 2011 Jul;3(3):205-10. doi: 10.4161/derm.3.3.16519. Epub 2011 Jul 1.
5
Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial.钙和维生素 D 补充剂与非黑素瘤和黑素瘤皮肤癌风险:妇女健康倡议随机对照试验的事后分析。
J Clin Oncol. 2011 Aug 1;29(22):3078-84. doi: 10.1200/JCO.2011.34.5967. Epub 2011 Jun 27.
6
Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.阳光暴露、维生素 D 受体多态性 FokI 和 BsmI 与多发性原发性黑色素瘤的风险。
Cancer Epidemiol. 2011 Dec;35(6):e105-10. doi: 10.1016/j.canep.2011.03.003. Epub 2011 May 25.
7
Vitamin D: an ancient hormone.维生素 D:一种古老的激素。
Exp Dermatol. 2011 Jan;20(1):7-13. doi: 10.1111/j.1600-0625.2010.01202.x.
8
Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers.诊断前血清 25-羟维生素 D 水平与乳腺癌、结直肠癌和其他癌症发病率的关系。
J Photochem Photobiol B. 2010 Nov 3;101(2):130-6. doi: 10.1016/j.jphotobiol.2010.04.008. Epub 2010 May 12.
9
Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.血清 25-羟维生素 D3 水平与黑色素瘤发病时的 Breslow 厚度和生存相关。
J Clin Oncol. 2009 Nov 10;27(32):5439-44. doi: 10.1200/JCO.2009.22.1135. Epub 2009 Sep 21.
10
Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.IV期黑色素瘤患者血清25-羟维生素D水平降低。
Anticancer Res. 2009 Sep;29(9):3669-74.